Kathrin Heinzmann

An empirical framework for binary interactome mapping

K. Venkatesan, Jean‐François Rual, Alexei Vázquez et al. · Nature Methods · 2008 · 908 citations · Full text

Life Sciences, Bioinformatics, Genetics +14

A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer

Sarah Halford, Gareth J. Veal, Stephen R. Wedge et al. · Clinical Cancer Research · 2023 · 219 citations · Full text

Medicine, Oncology, Pharmacology +10

AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity

Timothy A. Yap, Mike I. Walton, Kyla M. Grimshaw et al. · Clinical Cancer Research · 2012 · 91 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical translation of [18F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer

Suraiya Dubash, Shairoz Merchant, Kathrin Heinzmann et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I expansion study of the first-in-class monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL).

Sarah Halford, Harriet S. Walter, Pam McKay et al. · Journal of Clinical Oncology · 2021 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17